Origin
- Extract from a centralamerican
fern (Polypodium Leucotomos)
- Plant originally grew in the water
- developed a natural protection
mechanism against UV radiation
Quality
- Grows under controlled biological conditions
- No use of pesticides or chemicals
- Uniformly high quality and safety by
extraction solely under standardized laboratory conditions
(based on strict pharmaceutical guidelines)
Technology
In collaboration with the Harvard Medical School and leading experts the international pharmaceutical company IFC Group developed a completely new photoimmunoprotection: FernblockĀ®
This patented topical and oral photoimmunoprotection:
- protects the immune system of the skin
- counteracts the light-induced skin aging (photoaging)
- protects against free radicals
- protects the DNA
U.S.Patent No.: 5.614.197
The FernblockĀ® technology was developed by Prof. Fitzpatrick in more than 10 years of research at the renowned Harvard Medical School, Boston, USA.
Thomas B. Fitzpatrick (1919-2003)
Professor at Harvard Medical School in Boston
and head physician of Dermatology
at Massachusetts General Hospital (1959-1987)
Discoverer of the melanosomes
Introduction of PUVA therapy
More than 250 scientific publications during his 50-year
activity
activity